A covalent tumor-targeted theranostic system for NIR imaging-guided photodynamic-ferroptosis synergistic therapy of lung cancer

Yurong Fan Hongyuan Wen Zhitao Zhu Chaoxiang Cui Yu-Qi Zhang Zhongsheng Zhao Miao Li Yiming Feng Mei Hu Xingxiang Ren Zhengzhong Lv Zhixin Han Haibin Shi Guohua Fan

Jul 2026 · Science China Materials · Vol 69, pp. 5180 - 5190 · 0 citations · 38 references

TL;DR

DIR-CDF can specifically target integrin αvβ3-positive NSCLC and is covalently anchored within the tumors through the specific reaction between 1,3-cyclohexanedione and sulfenic acid, which significantly enhances the accumulation and retention of dIR-CDF in tumors.

DOI Semantic Scholar

View source

Similar papers

Review Sep 2026

Cell targeting peptide guided nanomedicine: a new paradigm in precision oncology for the management of non-small cell lung cancer.

The current review elucidates the pathophysiological complexity of NSCLC and prominent overexpressed receptors that can be harnessed for peptide-mediated targeting while critically evaluating the applications of CTP-functionalized NCs in chemotherapy, immunotherapy, phototherapy, gene delivery and tumor imaging.

Prerana Shetty, Shalini Shukla, Vivek Phatale et al. · International journal of pha... · 0 citations

Review Open access Sep 2026

Smart Theranostic Nanoplatforms in Oral Squamous Cell Carcinoma: Integrating Diagnosis, Targeted Therapy and Synergistic Photothermal/Photodynamic Approaches

Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity and is still associated with a poor prognosis today. Although surgery, radiotherapy, chemotherapy, and more recently immunotherapy and targeted therapies have improved the clinical management of the disease, their efficacy is ofte...

Ludovica Lucchesi Palli, C. Scialabba, G. Cavallaro · International Journal of Mol... · 0 citations

Open access Sep 2026

Programmable Organic A2S-TT NPs for NIR-II/Photoacoustic Imaging-Enabled Precision Therapy

Background: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by significant treatment challenges and poor prognosis. Traditional therapies such as surgical resection, radiotherapy, and chemotherapy often suffer from limitations including insufficient therapeutic specifi...

Wei Sang, Yi-Jun Huang, Jia-Hui Wen et al. · Pharmaceutics · 0 citations

Sep 2026

Spectroscopic insights and theranostic application of a CD44-targeted, GSH/H2S-dual-responsive AIE micellar nanoplatform for targeted tumor imaging and photodynamic therapy.

Stimuli-responsive theranostic nanoplatforms have garnered significant attention for their potential to boost diagnostic precision and photodynamic therapy (PDT) efficacy in cancer treatment. Here, we engineered a tumor microenvironment (TME) dual-responsive aggregation-induced emission (AIE) micellar system (HA-SS-TPE...

Lei Chen, Shan-Shan Jiang, Jin-Hui Wang et al. · Spectrochimica Acta Part A -... · 0 citations

Open access Aug 2026

Therapeutic transformation of a rhodium nanophotosensitizer into a tamoxifen-loaded targeted nano-drug for dual chemo-photodynamic therapy of ER-positive breast cancer.

Rhodium-based nanophotosensitizers have recently emerged as promising platforms for near-infrared (NIR)-activated photodynamic therapy (PDT). However, their therapeutic potential remains largely restricted to reactive oxygen species-mediated cytotoxicity, limiting their ability to address the complex molecular drivers...

Andres Machuca, Alejandro García García, Estefanía García-Calvo et al. · Colloids and Surfaces B: Bio... · 0 citations

Sep 2026

FAP-targeted gold nanocluster-mediated radioligand therapy in combination with TGF-βRI inhibition for tumor therapy.

Targeted radioligand therapy (TRT) is an emerging treatment modality that selectively delivers radioisotopes to tumors while sparing healthy tissues. However, optimizing TRT radiopharmaceuticals to concurrently achieve sustained tumor retention and rapid systemic clearance remains a fundamental challenge. Gold nanoclus...

Hui-Zhen Yang, Liu Liu, Guoping Jia et al. · Biomaterials · 0 citations